Our product range includes a wide range of 75iu ivf m hp injection, daunotec daunorubicin 20mg injection, 100mg oxaltero injection, 2mg bortenat bortezomib injection, 440mg vivitra injection and trustuzumab eleftha 440mg injection herceptin.
₹ 1999 Get Latest Price
Strength | 75iu |
Packaging Type | Vial |
Manufactured By | Cipla Ltd |
Injection Site | subcutaneously |
Salt | Menotrophin (75IU) |
Usage/Application | Female infertility, Male hypogonadism, Male infertility |
Country of Origin | Made in India |
₹ 333 Get Latest Price
Strength | 20 mg |
Pack Type | Vial |
Brand Name | Daunotec, Cerubidine, DaunoXome |
Manufacturer | Cipla Ltd |
Usages | Acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) |
Composition | Daunorubicin 20mg |
₹ 1999 Get Latest Price
Dose/Strength | 100 mg /50 ml |
Packaging Type | Box |
Manufacturer | Hetero Healthcare Limited |
Shelf Life | 24 Months |
Compostion | Oxaliplatin |
Prescription/Non prescription | Non prescription |
₹ 1999 Get Latest Price
Strength | 2 mg |
Packaging Type | Vial |
Brand | Bortenat |
Treatment | Multiple myeloma / Mantle-cell lymphoma |
Manufacturer | Natco Pharma Ltd |
Composition | Bortezomib |
₹ 58633.92 Get Latest Price
Strength | 440 mg |
Packaging Type | Box |
Brand Name | Vivitra |
Manufactured By | Zydus Cadila |
Usage | Clinical |
Composition | Trastuzumab |
₹ 13499 Get Latest Price
Strength | 440 mg |
Packaging Type | Vial |
Brand Name | Eleftha Herceptin |
Manufactured By | Intas Pharmaceuticals Ltd |
Shelf Life | 24 Months |
Treatment | HER2-positive breast cancer,HER2-positive metastatic gastric cancer |
Composition | Trastuzumab Lyophilized |
₹ 999 Get Latest Price
Strength | 100000 I.U/Vial |
Packaging Type | Vial |
Brand | Ulihope |
Manufacturer | Ulrich |
Shelf Life | 24 Months |
Treatment | Treat severe sepsis and acute pancreatitis, it is marketed under the brand name Ulihope |
₹ 799 Get Latest Price
Strength | 1 mg/ 1ml |
Brand | Oncovin VINCRISTINE |
Manufacturer | GLS Pharma Ltd. |
Compostion | Vincristine Sulfate 1mg |
Treatment | Cancer treatment (leukemia, lymphoma) |
Vincristine 1mg is an injectable chemotherapy medication used primarily in the treatment of various cancers, including leukemia, lymphoma, and other malignancies. It works by inhibiting the growth of cancer cells by blocking cell division, making it a crucial drug in combination cancer therapies.
Indications for Vincristine include:
Dosage and Administration:
Common side effects of Vincristine may include:
Packaging:
Vincristine 1mg is typically available in 1mg/1ml sterile injection vials for single-use.
Vincristine is an essential part of many chemotherapy regimens due to its effectiveness in stopping cancer cell growth.
₹ 7999 Get Latest Price
Strength | 100 mg |
Form | Injection |
Treatment | Colorectal cancer, head and neck cancer. |
Composition | Cetuximab |
Packaging Size | 20 ml |
Brand | Cetuxa, Erbitux |
Manufacturer | Alkem Laboratories Ltd |
Cetuxa 100 mg Cetuximab Injection contains Cetuximab, a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on the surface of cancer cells. By binding to EGFR, Cetuximab inhibits cell growth and promotes apoptosis (programmed cell death), making it effective in the treatment of certain types of cancers, particularly colorectal cancer and squamous cell carcinoma of the head and neck.
Common indications for Cetuxa 100 mg Injection include:
Dosage and Administration:
Common side effects of Cetuxa 100 mg Injection may include:
Serious side effects can include severe infusion reactions, cardiopulmonary arrest, and interstitial lung disease. Immediate medical attention is required if any severe reactions occur during or after the infusion.
Packaging:
Cetuxa 100 mg Cetuximab Injection is typically packaged in single-use vials containing a 100 mg/20 ml solution, with clear instructions for dilution and administration.
Cetuxa 100 mg Cetuximab Injection is a targeted cancer therapy used in the treatment of specific types of cancer, providing an important option for patients with advanced colorectal and head and neck cancers.
₹ 16035 Get Latest Price
Strength | 100 mg |
Packaging Type | Vial |
Treatment | Multiple myeloma |
Compositionn | Daratumumab |
Strengths | 100mg 400mg |
Manufacturer | JOHNSON & JOHNSON PVT LTD |
Darzalex 100mg injection is a targeted therapy for cancer containing the active ingredient Daratumumab, which belongs to the group of medicine called monoclonal antibodies. Monoclonal antibodies are proteins that recognize and attach to the specific target, killing the cancer cells. It is used to treat a type of cancer called multiple myeloma (bone marrow cancer) in adults 18 years or older. Report to your doctor if you have ever had a hepatitis B infection; this medicine may cause the hepatitis B virus to become active again. This medicine can decrease platelets (helps in blood clotting) and white blood cell counts (helps fight infections).
Do not take a Darzalex 100mg injection if you are allergic to Daratumumab or other medicine ingredients. This medicine is not recommended for children and adolescents. Inform your doctor if you get any infusion-related reactions, such as swollen face, lips, mouth, tongue, or throat. If you notice any infusion reactions, you need other medicine, or the infusion will be slowed down or stopped.
Consult your doctor if you are on a salt-controlled diet, as this medicine contains sodium. Tell your physician if you have a history of breathing problems (asthma or chronic obstructive pulmonary disease) or had shingles before taking Darzalex 100mg. This medicine can change the results of blood tests to match your blood type. You must tell your healthcare provider you are being treated with this medicine before receiving blood transfusions. Inform your doctor if you are pregnant or planning to get pregnant. Use effective contraception during and after the treatment for three months.
Uses of Darzalex 100mg InjectionTherapeutic Effects of Darzalex 100mg Injection
Darzalex 100mg binds specifically to a protein called CD38 found on the surface of multiple myeloma cells. This binding can trigger the immune system to attack and kill the cancer cells.
Interaction of Darzalex 100mg Injection with other drugsInform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional, supplements, and herbal products. In particular, tell your doctor if you are taking medicines for blood pressure or other heart conditions. Certain medications may interact with Darzalex 100mg and reduce its effectiveness by causing undesirable side effects.
More Information about Darzalex 100mg InjectionA trained doctor or nurse should only administer Darzalex 100mg. Do not self-administer the injection. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for unwanted side effects.
₹ 1666 Get Latest Price
Strength | 5000 IU |
Packaging Size | 0.3ml PFS |
Brand | Neo Recormon, Eprex, Binocrit, Mircera |
Manufactured By | Roche Products India Pvt Ltd |
Treatment | Anemia associated with chronic kidney disease, anemia in cancer patients undergoing chemotherapy, an |
Composition | Epoetin Beta |
₹ 222 Get Latest Price
Strength | 1 g |
Form | Injection |
Compostion | Cyclophosphamide |
Treatment | Various types of cancers, including lymphomas, leukemia, and breast cancer, as well as autoimmune di |
Manfuacturer | ZEE LABORATORIES LTD |
Nuphos Cyclophosphamide 1000mg Injection contains Cyclophosphamide, an alkylating agent used in the treatment of various cancers and certain autoimmune disorders. Cyclophosphamide works by interfering with the growth of cancer cells, slowing or stopping their proliferation. It is a widely used chemotherapeutic agent due to its broad spectrum of activity against many types of tumors.
Common indications for Nuphos Cyclophosphamide Injection include:
Dosage and Administration:
Nuphos Cyclophosphamide Injection is administered intravenously by a healthcare professional. The dosage depends on the type of cancer, the patient's size, and their response to treatment. The injection is typically given as part of a combination chemotherapy regimen. Hydration before and after administration is important to prevent bladder toxicity.
Common side effects of Nuphos Cyclophosphamide Injection may include:
More serious side effects can include bone marrow suppression leading to anemia, leukopenia (low white blood cell count), and thrombocytopenia (low platelet count), as well as bladder toxicity, hemorrhagic cystitis, and an increased risk of infections. Regular monitoring of blood counts and kidney function is essential during treatment.
Packaging:
Nuphos Cyclophosphamide 1000mg Injection is typically available in single-use vials, which must be reconstituted with a sterile diluent before intravenous administration.
Nuphos Cyclophosphamide 1000mg Injection is a critical component in the treatment of various cancers and certain autoimmune disorders. It requires careful handling and administration by healthcare professionals to ensure patient safety and therapeutic efficacy. Regular monitoring and supportive care are necessary to manage side effects and to maximize the treatment benefits.
₹ 2999 Get Latest Price
Packaging Size | 1X0.6 ml Vial |
Strength | 6 mg/ 0.6 ml |
Compostion | Pegfilgrastim (6mg) |
Treatment | Prevention of Infections after chemotherapy |
Manufacturer | Dr Reddy's Laboratories Ltd |
₹ 4999 Get Latest Price
Packaging Size | 1X0.6 ml Vial |
Strength | 6 mg/ 0.6 ml |
Form | Injection |
Brand Names | Pegstim, Neulasta, Fulphila |
Composition | Pegfilgrastim |
Treatment | Used to reduce the risk of infection during chemotherapy by stimulating the growth of white blood ce |
Manufacturer | Zydus Cadila |
₹ 111111 Get Latest Price
Compositionv | Inclisiran |
Strength | 284 mg |
Brand Names | Leqvio |
Manufacturer | Novartis Pharmaceuticals |
Packaging | Single-use pre-filled syringe |
Treatment | Hypercholesterolemia, Atherosclerotic Cardiovascular Disease (ASCVD), Familial Hypercholesterolemia |
Inclisiran 284 mg Injection contains Inclisiran, a small interfering RNA (siRNA) medication used to lower cholesterol levels in the blood. It is specifically indicated for the treatment of hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH) and atherosclerotic cardiovascular disease (ASCVD) in adults who require additional lowering of LDL cholesterol.
Inclisiran is available in a strength of 284 mg per injection and is typically packaged as a single-use pre-filled syringe. This convenient packaging allows for easy administration, usually performed by a healthcare professional.
The active ingredient, Inclisiran, works by targeting and degrading the messenger RNA (mRNA) that encodes for the protein PCSK9 (proprotein convertase subtilisin/kexin type 9). By reducing the production of PCSK9, Inclisiran increases the number of LDL receptors on the surface of liver cells, enhancing the clearance of LDL cholesterol from the blood. This mechanism of action leads to a significant reduction in LDL cholesterol levels.
The usual dosage of Inclisiran involves an initial injection, followed by a second dose at 3 months, and subsequent doses every 6 months. This biannual dosing schedule offers a convenient and effective approach to managing cholesterol levels, especially for patients who may have difficulty adhering to daily medications.
Common side effects of Inclisiran may include injection site reactions, such as redness, pain, or swelling. These side effects are generally mild and temporary. However, any severe or persistent side effects should be reported to a healthcare provider promptly.
Inclisiran is manufactured by Novartis Pharmaceuticals, a leading global healthcare company known for its innovative treatments and commitment to improving patient outcomes. Regular monitoring of cholesterol levels and follow-ups with the healthcare provider are essential to assess the effectiveness of Inclisiran and make any necessary adjustments to the treatment plan.
Inclisiran 284 mg Injection provides a groundbreaking solution for managing high cholesterol levels, particularly in patients with ASCVD and familial hypercholesterolemia. Its novel siRNA mechanism offers a new approach to cholesterol reduction, helping to reduce the risk of cardiovascular events and improve overall cardiovascular health. With its convenient dosing schedule and proven efficacy, Inclisiran represents a significant advancement in lipid management therapy.
₹ 546 Get Latest Price
Strength | 200 mg |
Pack Type | Vial |
Brand Name | Celdaz |
Manufacturer | Celon Laboratories Ltd |
Usages | To treat various types of cancer |
Composition | Dacarbazine |
Treatment | Metastatic Malignant Melanoma: A type of skin cancer that has spread to other parts of the body. Ho |
₹ 555 Get Latest Price
Strength | 1 g |
Packaging Type | Vial |
Brand | Ipoget, Holoxan, Ifosfamide Ebewe |
Manufacturer | GLS Pharma Ltd |
Composition | IFOSFAMIDE, MESNA |
Treatment | Cancer (testicular cancer, sarcomas, and other solid tumors) |
₹ 2111 Get Latest Price
Strength | 100 mg |
Salt Name | Bendamustine |
Brand Name | Bendamax, Treanda, Bendit |
Composition | Bendamustine |
Treatment | Chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL) |
₹ 222 Get Latest Price
Strength | 0.5 mg/ml |
Composition | Cisplatin (10mg) |
Brand Names | Kemoplat, Platinol, Cisplatin Injection |
Treatment | Cancer treatment (including testicular, ovarian, bladder, and other cancers) |
Manufacturer | Fresenius Kabi India Pvt Ltd |
₹ 19999 Get Latest Price
Strength | 500 mg |
Packaging Type | Box |
Packaging Size | 50 ml |
Brand | Enfiera |
Manufacturer | Zydus Lifesciences Ltd |
Composition | Rituximab |
Treatment | Treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer |
₹ 999 Get Latest Price
Strength | 10 mg |
Packaging Size | 1*10 Capsules |
Packaging Type | Box |
Brand | lenvatol 10 |
Manufactured By | Cipla |
₹ 6300 Get Latest Price
Dose/Strength | 100 mg |
Packaging Type | Box |
Form of Medicine | Injection |
Product Type | Finished Product |
Packaging Size | medium |
Oxidach Injection contains Doxycycline Hydrochloride 100 mg, a broad-spectrum antibiotic belonging to the tetracycline class. It is used to treat a wide range of bacterial infections by inhibiting the growth of bacteria.
This injection is typically administered intravenously (IV) or intramuscularly (IM) in clinical settings, especially when oral administration is not feasible
₹ 5072.98 Get Latest Price
Dose/Strength | 50 mg /10 ml |
Packaging Type | Vial |
Brand | Oxitan |
Manufacturer | Fresenius |
Gender | Unisex |
Company | Fresenius |
Dose/Strength . | 100mg |
Oxitan 100 mg Injection contains Oxaliplatin, a platinum-based chemotherapy drug used to treat advanced colorectal cancer. It works by inhibiting DNA synthesis and repair in cancer cells, ultimately causing their death. Oxitan is usually used in combination with other chemotherapy agents such as 5-Fluorouracil (5-FU) and leucovorin.
John (Manager)
Healsglobe Exports Private Limited
147,Ground Floor,Quarter,V H B Colony
Nagpur - 440009, Maharashtra, India